相关实验视频

Updated: Jul 6, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

缺氧诱导因子prolyl氧酶抑制剂:元分析可以告诉我们什么

Francesco Locatelli¹, Carmine Zoccali²

¹Department of Nephrology, Alessandro Manzoni Hospital, Lecco, Italy.

Clinical kidney journal

|January 8, 2024

概括

缺氧诱导因子基酶抑制剂 (HIF-PHI) 与红色素形成刺激剂 (ESA) 相比,显示出有效性和安全性. 然而,临床意义和混因素,如铁状况,需要在元分析中仔细考虑.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
药理学药理学是指药理学的学科.
临床试验临床试验

背景情况:

分析对于合成研究是有价值的,但有风险过度强调统计而不是临床意义.
在元分析中对临床意义的标准化报告仍然是一个挑战.
红色素形成刺激剂 (ESAs) 通常用于治疗脏疾病中的贫血.

研究的目的:

评估低氧诱导因子酸酶抑制剂 (HIF-PHI) 作为一类和单独的疗效和安全性.
在随机对照试验 (RCT) 中,将HIF-PHI与红色形成刺激剂 (ESA) 进行比较.
在透析和非透析患者中评估HIF-PHI.

主要方法:

第三阶段随机临床试验 (RCT) 的系统审查和元分析.
包括的研究直接将HIF-PHI与ESA进行了比较.
关注涉及透析和非透析人群的试验.

主要成果:

HIF-PHI的有效性和安全性与ESA相提并论.
分析强调了对标准化初级终点的需求,例如持续实现血红蛋白目标.
混因素如注射铁,铁储量和炎症影响可靠性.

结论:

高高度PHI代表了对贫血的可行的治疗选择,为ESAs提供了替代方案.
分析必须优先考虑临床上有意义的结果,并解决潜在的混因素,以准确解释.
进一步的研究应该集中在临床意义和剂量特定比较的标准化报告上.

关键词:

在CKD中,它是CKD.透析是通过透析进行的.激发红色素形成的刺激剂.缺氧诱导因子 prolyl氧酶抑制剂这是一个元分析.

更多相关视频

Induction and Testing of Hypoxia in Cell Culture

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Peroxisomes

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...